INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Teva Pharmaceutical Industries Limited & Encourages Investors...
04 Novembre 2016 - 5:20PM
Business Wire
Khang & Khang LLP (the “Firm”) announces that it is
investigating claims against Teva Pharmaceutical Industries Limited
(“Teva” or the “Company”) (NYSE: TEVA) concerning possible
violations of federal securities laws.
If you purchased shares of Teva and want more information,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
The investigation concerns whether Teva and certain of its
officers and/or directors violated federal securities laws. On
November 3, 2016, Bloomberg News reported that the Justice
Department is conducting an antitrust investigation of over a dozen
companies, including Teva, to determine whether they unlawfully
colluded with each other to fix generic drug prices.
If you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161104005788/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024